Pages that link to "Q39297461"

The following pages link to The role of N-methyl-D-aspartate receptor subunit NR2B in spinal cord in cancer pain (Q39297461):

Displaying 35 items.

• A polyamine-deficient diet prevents oxaliplatin-induced acute cold and mechanical hypersensitivity in rats (Q28534748) (← links)
• Dissociation between the relief of skeletal pain behaviors and skin hypersensitivity in a model of bone cancer pain (Q30831131) (← links)
• PAR2-mediated upregulation of BDNF contributes to central sensitization in bone cancer pain (Q33637280) (← links)
• The Src family kinase inhibitor dasatinib delays pain-related behaviour and conserves bone in a rat model of cancer-induced bone pain (Q33881060) (← links)
• The neurobiology of cancer pain (Q34167635) (← links)
• Intraperitoneal Injection of Thalidomide Attenuates Bone Cancer Pain and Decreases Spinal Tumor Necrosis Factor-α Expression in a Mouse Model (Q34221568) (← links)
• Intrathecal injection of spironolactone attenuates radicular pain by inhibition of spinal microglia activation in a rat model (Q34328380) (← links)
• Senegenin attenuates hepatic ischemia-reperfusion induced cognitive dysfunction by increasing hippocampal NR2B expression in rats (Q34429471) (← links)
• Bone cancer induces a unique central sensitization through synaptic changes in a wide area of the spinal cord (Q34489274) (← links)
• TargetingN-methyl-D-aspartate receptors for treatment of neuropathic pain (Q35041376) (← links)
• 2020 foresight: Envisioning therapeutic innovations for pain (Q35069143) (← links)
• Activation of spinal alpha-7 nicotinic acetylcholine receptor attenuates remifentanil-induced postoperative hyperalgesia (Q35479514) (← links)
• Mas-Related Gene (Mrg) C Activation Attenuates Bone Cancer Pain via Modulating Gi and NR2B (Q36010727) (← links)
• Activation of c-jun N-terminal kinase in spinal cord contributes to breast cancer induced bone pain in rats (Q36125514) (← links)
• Analgesic effects of NB001 on mouse models of arthralgia (Q36139992) (← links)
• Overview of Glutamatergic Dysregulation in Central Pathologies (Q36409596) (← links)
• Role of nitric oxide synthase in the development of bone cancer pain and effect of L-NMMA (Q36520170) (← links)
• Activation of spinal MrgC-Gi-NR2B-nNOS signaling pathway by Mas oncogene-related gene C receptor agonist bovine adrenal medulla 8-22 attenuates bone cancer pain in mice (Q36841355) (← links)
• CREB-regulated transcription coactivator 1 enhances CREB-dependent gene expression in spinal cord to maintain the bone cancer pain in mice (Q37114764) (← links)
• Negative regulation of REST on NR2B in spinal cord contributes to the development of bone cancer pain in mice (Q37709186) (← links)
• Glutamate signaling in healthy and diseased bone (Q38029596) (← links)
• Calcium-permeable ion channels in pain signaling (Q38175134) (← links)
• Efficacy of Continuous S( )-Ketamine Infusion for Postoperative Pain Control: A Randomized Placebo-Controlled Trial (Q38494461) (← links)
• A Single Intrathecal or Intraperitoneal Injection of CB2 Receptor Agonist Attenuates Bone Cancer Pain and Induces a Time-Dependent Modification of GRK2. (Q38789599) (← links)
• Intrathecal administration of roscovitine attenuates cancer pain and inhibits the expression of NMDA receptor 2B subunit mRNA (Q39364700) (← links)
• Tyrosine phosphorylation of the N-Methyl-D-Aspartate receptor 2B subunit in spinal cord contributes to remifentanil-induced postoperative hyperalgesia: the preventive effect of ketamine (Q41993519) (← links)
• Effects of Src-kinase inhibition in cancer-induced bone pain. (Q42409094) (← links)
• Intrathecal Administration of the Cannabinoid 2 Receptor Agonist JWH015 Can Attenuate Cancer Pain and Decrease mRNA Expression of the 2B Subunit of N-Methyl-D-Aspartic Acid (Q45022930) (← links)
• Potentiation of acute morphine‐induced analgesia measured by a thermal test in bone cancer‐bearing mice (Q46441995) (← links)
• Anxiolytic-like effects of α-asarone in a mouse model of chronic pain (Q47980674) (← links)
• Brain-derived neurotrophic factor modulates N-methyl-D-aspartate receptor activation in a rat model of cancer-induced bone pain (Q48648830) (← links)
• Analgesic Effect of Intrathecal Administration of Chemokine Receptor CCR2 Antagonist is Related to Change in Spinal NR2B, nNOS, and SIGIRR Expression in Rat with Bone Cancer Pain (Q51059261) (← links)
• Intrathecal Injection of JWH-015 Attenuates Bone Cancer Pain Via Time-Dependent Modification of Pro-inflammatory Cytokines Expression and Astrocytes Activity in Spinal Cord. (Q53533652) (← links)
• Chemokine receptor CCR2 contributes to neuropathic pain and the associated depression via increasing NR2B-mediated currents in both D1 and D2 dopamine receptor-containing medium spiny neurons in the nucleus accumbens shell (Q89545828) (← links)
• The Ubiquitination of Spinal MrgC Alleviates Bone Cancer Pain and Reduces Intracellular Calcium Concentration in Spinal Neurons in Mice (Q90084665) (← links)